Wspólnotowy Serwis Informacyjny Badan i Rozwoju - CORDIS

A lipidated derivative of ApoE-derived peptide sequence forms nano-carriers

We introduced and characterised the novel chimerical lipopeptide P2A2, which is a highly promising candidate for drug delivery from micellar and liposomal nanoparticles owing to its straightforward synthesis, its unique physicochemical properties and its adaptability to a broad spectrum of targets. P2A2 consists of a strongly cationic, ApoE-based peptide, which is able to overcome cell membranes, and two palmitoyl chains promote detergent-like aggregation and partitioning into lipid bilayers. Biophysical experiments revealed that the lipopeptide self-assembled into small micelles comprising about 20 monomers. P2A2-lipid interactions were analysed and yielded a phase diagram permitting mastery of the colloidal state and thus rendering both micellar as well as liposomal formulations available for drug delivery.

Powiązane informacje


Margitta DATHE, (Group leader)
Tel.: +49-309-4793274
Faks: +49-309-4793159
Adres e-mail
Śledź nas na: RSS Facebook Twitter YouTube Zarządzany przez Urząd Publikacji UE W górę